Healthcare | March 11, 2024
LVPEI observes World Glaucoma Week
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Vision loss due to Glaucoma can be prevented if it is detected and treated early
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease
Appoints Dr Rafiq Hasan as CEO
Acquisition will add GT005 to the Novartis portfolio, an investigational, one-time gene therapy currently in Phase 2 for the treatment of people living with Geographic atrophy
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
Subscribe To Our Newsletter & Stay Updated
